Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

CMV-MVA Triplex Vaccination of Stem Cell Donors to Enhance CMV Specific Immunity and Prevent CMV Viremia in Recipients After Stem Cell Transplant

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03560752
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:52.314387+00:00
Published At
2024-01-31T00:00:00+00:00
Record Updated At
2025-12-10
Results Posted At
2024-01-31
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Accelerated Phase CML, BCR-ABL1 Positive", "Acute Lymphoblastic Leukemia in Remission", "Acute Myeloid Leukemia in Remission", "Chronic Lymphocytic Leukemia", "Chronic Phase CML, BCR-ABL1 Positive", "Cytomegalovirus Positive", "Donor", "Hematopoietic Cell Transplant Recipient", "Hodgkin Lymphoma", "Myelodysplastic Syndrome", "Myelodysplastic/Myeloproliferative Neoplasm", "Non-Hodgkin Lymphoma", "Myelofibrosis", "Hematopoietic and Lymphoid Cell Neoplasm"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-12-10"
protocolSection.identificationModule.nctId
"NCT03560752"
protocolSection.identificationModule.officialTitle
"CMV-MVA Triplex Vaccination of Stem Cell Donors to Enhance CMV Specific Immunity and Prevent CMV Viremia in Recipients After Stem Cell Transplant"
protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2024-01-31"

Study condition terms

  • Accelerated Phase CML, BCR-ABL1 Positive (protocolSection.conditionsModule.conditions)
  • Acute Lymphoblastic Leukemia in Remission (protocolSection.conditionsModule.conditions)
  • Acute Myeloid Leukemia in Remission (protocolSection.conditionsModule.conditions)
  • Chronic Lymphocytic Leukemia (protocolSection.conditionsModule.conditions)
  • Chronic Phase CML, BCR-ABL1 Positive (protocolSection.conditionsModule.conditions)
  • Cytomegalovirus Positive (protocolSection.conditionsModule.conditions)
  • Donor (protocolSection.conditionsModule.conditions)
  • Hematopoietic Cell Transplant Recipient (protocolSection.conditionsModule.conditions)
  • Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Myelodysplastic Syndrome (protocolSection.conditionsModule.conditions)
  • Myelodysplastic/Myeloproliferative Neoplasm (protocolSection.conditionsModule.conditions)
  • Non-Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Myelofibrosis (protocolSection.conditionsModule.conditions)
  • Hematopoietic and Lymphoid Cell Neoplasm (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.